Revisiting entinostat as an immune-potentiating adjuvant

Oncotarget. 2018 Dec 18;9(99):37278-37279. doi: 10.18632/oncotarget.26453.
No abstract available

Keywords: adjuvant; entinostat; histone deacetylase inhibitor; immunotherapy; ovarian cancer.

Publication types

  • Editorial